Oramed Pharmaceuticals Inc. (ORMP)
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptide-1 capsule that has completed phase I clinical trials for the treatment of type 2 diabetes; and a weight loss treatment in the form of an oral leptin capsule. The company was formerly known as Integrated Security Technologies, Inc. and changed its name to Oramed Pharmaceuticals Inc. in April 2006. Oramed Pharmaceuticals Inc. was founded in 2002 and is based in New York, New York.
$98.66M
Mr. Nadav Kidron Esq.
13.00
New York, NY
Apr 01, 2002
4.75
$0.51
0.07
2.25
-463.73%
-16.34
-6.30
0.68
76.37
2.25
-2.69%
-4.13%
Similar stocks (19)
ImmunityBio, Inc.
IBRX
Ardelyx, Inc.
ARDX
Terns Pharmaceuticals, Inc.
TERN
Lexicon Pharmaceuticals, Inc.
LXRX
Inozyme Pharma, Inc.
INZY
Aldeyra Therapeutics, Inc.
ALDX
Corvus Pharmaceuticals, Inc.
CRVS
Seres Therapeutics, Inc.
MCRB
X4 Pharmaceuticals, Inc.
XFOR
Leap Therapeutics, Inc.
LPTX
Checkpoint Therapeutics, Inc.
CKPT
Protalix BioTherapeutics, Inc.
PLX
Immix Biopharma, Inc.
IMMX
Elevation Oncology, Inc.
ELEV
Ocean Biomedical, Inc.
OCEA
Palisade Bio, Inc.
PALI
Enveric Biosciences, Inc.
ENVB
Hepion Pharmaceuticals, Inc.
HEPA
CohBar, Inc.
CWBR
ETF Exposure (6)
iShares Micro-Cap ETF
IWC
0.02364%
SPDR S&P International Small Cap ETF
GWX
0.004403%
SPDR Portfolio Developed World ex-US ETF
SPDW
5.22e-4%
Dimensional U.S. Small Cap ETF
DFAS
1.786e-4%
Dimensional U.S. Targeted Value ETF
DFAT
1.4885e-4%
Dimensional U.S. Equity ETF
DFUS
7.948e-5%
Similar stocks (19)
ImmunityBio, Inc.
IBRX
Ardelyx, Inc.
ARDX
Terns Pharmaceuticals, Inc.
TERN
Lexicon Pharmaceuticals, Inc.
LXRX
Inozyme Pharma, Inc.
INZY
Aldeyra Therapeutics, Inc.
ALDX
Corvus Pharmaceuticals, Inc.
CRVS
Seres Therapeutics, Inc.
MCRB
X4 Pharmaceuticals, Inc.
XFOR
Leap Therapeutics, Inc.
LPTX
Checkpoint Therapeutics, Inc.
CKPT
Protalix BioTherapeutics, Inc.
PLX
Immix Biopharma, Inc.
IMMX
Elevation Oncology, Inc.
ELEV
Ocean Biomedical, Inc.
OCEA
Palisade Bio, Inc.
PALI
Enveric Biosciences, Inc.
ENVB
Hepion Pharmaceuticals, Inc.
HEPA
CohBar, Inc.
CWBR
ETF Exposure (6)
iShares Micro-Cap ETF
IWC
0.02364%
SPDR S&P International Small Cap ETF
GWX
0.004403%
SPDR Portfolio Developed World ex-US ETF
SPDW
5.22e-4%
Dimensional U.S. Small Cap ETF
DFAS
1.786e-4%
Dimensional U.S. Targeted Value ETF
DFAT
1.4885e-4%
Dimensional U.S. Equity ETF
DFUS
7.948e-5%